Graham Capital Management, L.P. Biotechnology

Graham Capital Management, L.P.

$5.17 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TBPH Theravance Biopharma, Inc.	$796M	$213,000 0.0% of portfolio	19,372	Q2 2025 Reduced 22.37%
PRTA Prothena Corp Public LTD CO	$354M	$206,000 0.0% of portfolio	34,042	Q2 2025 New
ITOS I Teos Therapeutics, Inc.	$359M	$205,000 0.0% of portfolio	20,637	Q2 2025 Reduced 49.26%
ABSI Absci Corp	$276M	$196,000 0.0% of portfolio	76,276	Q2 2025 New
BDTX Black Diamond Therapeutics, Inc.	$92.3M	$178,000 0.0% of portfolio	72,020	Q2 2025 New
CHRS Coherus Bio Sciences, Inc.	$71.5M	$168,000 0.0% of portfolio	231,255	Q2 2025 Added 46.39%
AUPH Aurinia Pharmaceuticals Inc.	$1.61B	$146,000 0.0% of portfolio	17,323	Q2 2025 Reduced 53.97%
CGEM Cullinan Oncology, Inc.	$332M	$145,000 0.0% of portfolio	19,277	Q2 2025 Reduced 34.67%
ENTA Enanta Pharmaceuticals Inc	$142M	$141,000 0.0% of portfolio	18,730	Q2 2025 Reduced 6.45%
AKBA Akebia Therapeutics, Inc.	$610M	$138,000 0.0% of portfolio	38,159	Q2 2025 Added 117.39%
DYN Dyne Therapeutics, Inc.	$602M	$128,000 0.0% of portfolio	13,488	Q2 2025 Reduced 78.34%
KOD Kodiak Sciences Inc.	$443M	$125,000 0.0% of portfolio	33,588	Q2 2025 Added 0.75%
FATE Fate Therapeutics Inc	$91.2M	$95,000 0.0% of portfolio	85,633	Q2 2025 Reduced 38.86%
VTYX Ventyx Biosciences, Inc.	$149M	$94,000 0.0% of portfolio	44,372	Q2 2025 Reduced 79.61%
THRD Third Harmonic Bio, Inc.	$217M	$92,000 0.0% of portfolio	17,112	Q2 2025 New
BCYC Bicycle Therapeutics PLC	$214M	$91,000 0.0% of portfolio	13,102	Q2 2025 New
AVIR Atea Pharmaceuticals, Inc.	$292M	$89,000 0.0% of portfolio	24,824	Q2 2025 Added 48.63%
EDIT Editas Medicine, Inc.	$157M	$89,000 0.0% of portfolio	40,633	Q2 2025 New
PGEN Precigen, Inc.	$375M	$84,000 0.0% of portfolio	59,425	Q2 2025 Added 425.47%
FULC Fulcrum Therapeutics, Inc.	$340M	$82,000 0.0% of portfolio	12,052	Q2 2025 Reduced 92.75%
COGT Cogent Biosciences, Inc.	$760M	$81,000 0.0% of portfolio	11,328	Q2 2025 Reduced 84.69%
ERAS Erasca, Inc.	$191M	$81,000 0.0% of portfolio	63,824	Q2 2025 Added 51.93%
CRDF Cardiff Oncology, Inc.	$105M	$58,000 0.0% of portfolio	18,718	Q2 2025 New
MREO Mereo Biopharma Group PLC	$207M	$57,000 0.0% of portfolio	21,176	Q2 2025 Reduced 57.15%
GOSS Gossamer Bio, Inc.	$181M	$57,000 0.0% of portfolio	46,894	Q2 2025 Added 61.83%
ZNTL Zentalis Pharmaceuticals, Inc.	$80.3M	$41,000 0.0% of portfolio	35,475	Q2 2025 Reduced 71.57%
SEER Seer, Inc.	$129M	$32,000 0.0% of portfolio	15,277	Q2 2025 New
ALEC Alector, Inc.	$165M	$29,000 0.0% of portfolio	21,373	Q2 2025 Reduced 48.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.